PT1423407E - Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos - Google Patents

Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos

Info

Publication number
PT1423407E
PT1423407E PT01978315T PT01978315T PT1423407E PT 1423407 E PT1423407 E PT 1423407E PT 01978315 T PT01978315 T PT 01978315T PT 01978315 T PT01978315 T PT 01978315T PT 1423407 E PT1423407 E PT 1423407E
Authority
PT
Portugal
Prior art keywords
compounds
pharmaceutical compositions
compositions containing
methylene
preparation
Prior art date
Application number
PT01978315T
Other languages
English (en)
Inventor
Menzenbach Bernd
Elger Walter
Droescher Peter
Hillisch Alexander
Kaufmann Guenter
Schweikert Hans-Udo
Mueller Gerd
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT1423407E publication Critical patent/PT1423407E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01978315T 2000-09-04 2001-08-29 Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos PT1423407E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10043846A DE10043846A1 (de) 2000-09-04 2000-09-04 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
PT1423407E true PT1423407E (pt) 2006-07-31

Family

ID=7655148

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01978315T PT1423407E (pt) 2000-09-04 2001-08-29 Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos

Country Status (29)

Country Link
EP (1) EP1423407B1 (pt)
JP (1) JP2004513084A (pt)
KR (1) KR100530816B1 (pt)
CN (1) CN1262560C (pt)
AT (1) ATE319733T1 (pt)
AU (2) AU2002210470B2 (pt)
BG (1) BG107594A (pt)
BR (1) BR0113618A (pt)
CA (1) CA2421302C (pt)
DE (2) DE10043846A1 (pt)
DK (1) DK1423407T3 (pt)
EA (1) EA006387B1 (pt)
EE (1) EE05186B1 (pt)
ES (1) ES2260294T3 (pt)
HK (1) HK1060135A1 (pt)
HR (1) HRP20030256A2 (pt)
HU (1) HUP0300936A3 (pt)
IL (2) IL154666A0 (pt)
ME (1) MEP14408A (pt)
MX (1) MXPA03001912A (pt)
NO (1) NO325012B1 (pt)
NZ (1) NZ524485A (pt)
PL (1) PL360669A1 (pt)
PT (1) PT1423407E (pt)
RS (1) RS50305B (pt)
SK (1) SK286757B6 (pt)
UA (1) UA74592C2 (pt)
WO (1) WO2002019971A1 (pt)
ZA (1) ZA200301715B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141984A1 (de) 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
US7199115B2 (en) 2004-04-19 2007-04-03 Schering Ag 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
DE202007019049U1 (de) * 2007-11-05 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Verwendung eines Gestagens in Kombination mit einem Estrogen zur Prophylaxe der Laktoseintoleranz bei der oralen Kontrazeption

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611773A (en) * 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US3146239A (en) * 1957-09-23 1964-08-25 Syntex Corp 4-halo-19-nor-progesterone
US3232960A (en) * 1959-10-08 1966-02-01 Upjohn Co 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
US4389345A (en) * 1981-10-09 1983-06-21 G.D. Searle & Co. 3-Oxoestra-17-acetonitrile and unsaturated analogs
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
AU2001268661A1 (en) * 2000-06-27 2002-01-08 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase

Also Published As

Publication number Publication date
SK286757B6 (sk) 2009-05-07
KR100530816B1 (ko) 2005-11-25
MXPA03001912A (es) 2004-07-08
KR20030028836A (ko) 2003-04-10
EE05186B1 (et) 2009-06-15
HK1060135A1 (en) 2004-07-30
HRP20030256A2 (en) 2005-10-31
WO2002019971A9 (de) 2002-08-08
ES2260294T3 (es) 2006-11-01
CN1262560C (zh) 2006-07-05
ATE319733T1 (de) 2006-03-15
AU2002210470B2 (en) 2006-07-20
EE200300087A (et) 2005-02-15
HUP0300936A3 (en) 2010-01-28
NO20030989D0 (no) 2003-03-03
PL360669A1 (en) 2004-09-20
WO2002019971A1 (de) 2002-03-14
CN1452628A (zh) 2003-10-29
EP1423407B1 (de) 2006-03-08
EP1423407A1 (de) 2004-06-02
DE10043846A1 (de) 2002-04-04
NZ524485A (en) 2005-11-25
CA2421302A1 (en) 2003-03-03
DK1423407T3 (da) 2006-07-03
BR0113618A (pt) 2003-07-15
IL154666A0 (en) 2003-09-17
SK2442003A3 (en) 2003-08-05
RS50305B (sr) 2009-09-08
UA74592C2 (en) 2006-01-16
YU16403A (sh) 2006-05-25
DE50109175D1 (de) 2006-05-04
JP2004513084A (ja) 2004-04-30
NO325012B1 (no) 2008-01-14
CA2421302C (en) 2007-08-14
BG107594A (bg) 2003-09-30
HUP0300936A2 (hu) 2003-11-28
IL154666A (en) 2008-12-29
EA006387B1 (ru) 2005-12-29
EA200300322A1 (ru) 2003-10-30
ZA200301715B (en) 2004-08-13
MEP14408A (en) 2010-06-10
NO20030989L (no) 2003-05-02
AU1047002A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
DE60141587D1 (de) Verfahren zur behandlung von erektionsstörungen und steigerung der libido bei männern
HUP0004339A2 (hu) Nõk kezelési eljárása menopauzát követõen ultra-alacsony dózisú ösztrogénnel
UA66861C2 (uk) 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
BR9903100A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em (-(
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
ATE333885T1 (de) Verwendung von sulodexid zur behandlung von reizdarm
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
JP2004508317A5 (pt)
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
PT1423407E (pt) Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos
HUP0101005A2 (hu) Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére
DE59907558D1 (de) Mittel zur stabilisierung von lebensmitteln und kosmetischen mitteln sowie verfahren zu dessen herstellung
JPH0733673A (ja) テストステロン−５α−リダクターゼ阻害剤
ATE470669T1 (de) D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere
WO2003045971A3 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
MD2519F1 (en) Cream for treatment of cutaneous affections
BR0016092A (pt) Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento
UA32236A (uk) Спосіб лікування гострого деструктивного панкреатиту